Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

OABI

OmniAb (OABI)

OmniAb Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OABI
DateTimeSourceHeadlineSymbolCompany
04/06/202421:20Business WireOmniAbが重鎖単一ドメイン抗体ニワトリプラットフォームに関する学術論文を米国免疫学会雑誌に発表NASDAQ:OABIOmniAb Inc
04/06/202406:05Business WireOmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of ImmunologyNASDAQ:OABIOmniAb Inc
20/05/202422:05Business WireOmniAb to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OABIOmniAb Inc
16/05/202406:05Business WireOmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston SummitNASDAQ:OABIOmniAb Inc
10/05/202406:05Business WireOmniAb Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
01/05/202422:00Business WireOmniAb to Participate in Five Investor Conferences in MayNASDAQ:OABIOmniAb Inc
22/04/202422:00Business WireOmniAb to Report First Quarter 2024 Financial Results on May 9NASDAQ:OABIOmniAb Inc
21/03/202407:05Business WireOmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
27/02/202400:00Business WireOmniAb to Report Fourth Quarter 2023 Financial Results on March 20NASDAQ:OABIOmniAb Inc
21/02/202400:00Business WireOmniAb to Participate in Two Investor Conferences in MarchNASDAQ:OABIOmniAb Inc
15/12/202308:30Business WireOmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics ConferenceNASDAQ:OABIOmniAb Inc
10/11/202309:55Business WireOmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual EventNASDAQ:OABIOmniAb Inc
10/11/202300:00Business WireOmniAb Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
02/11/202323:00Business WireOmniAb to Participate in Two Investor Conferences in NovemberNASDAQ:OABIOmniAb Inc
02/11/202300:00Business WireOmniAb Appoints Steve Love to its Board of DirectorsNASDAQ:OABIOmniAb Inc
01/11/202307:28Business WireOmniAb Announces Agenda for its Research & Technology Virtual EventNASDAQ:OABIOmniAb Inc
12/10/202323:00Business WireOmniAb to Hold Research & Technology Virtual Event on November 9NASDAQ:OABIOmniAb Inc
05/09/202322:00Business WireOmniAb to Participate in Two Investor Conferences in SeptemberNASDAQ:OABIOmniAb Inc
11/08/202306:05Business WireOmniAb Reports Second Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
08/08/202306:05Business WireOmniAb Announces the Passing of Director Sunil PatelNASDAQ:OABIOmniAb Inc
31/07/202322:00Business WireOmniAb to Report Second Quarter 2023 Financial Results on August 10NASDAQ:OABIOmniAb Inc
18/05/202306:05Business WireOmniAb Launches OmniDeep™ at the PEGS Boston Conference and ExpoNASDAQ:OABIOmniAb Inc
11/05/202321:00Business WireOmniAb Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
01/05/202322:00Business WireOmniAb to Report First Quarter 2023 Financial Results on May 11NASDAQ:OABIOmniAb Inc
25/04/202322:00Business WireOmniAb to Participate in Upcoming Investor Conferences in MayNASDAQ:OABIOmniAb Inc
31/03/202307:05Business WireOmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
10/03/202300:00Business WireOmniAb to Report Fourth Quarter 2022 Financial Results on March 30NASDAQ:OABIOmniAb Inc
08/02/202300:00Business WireOmniAb to Participate in Three Upcoming Investor ConferencesNASDAQ:OABIOmniAb Inc
02/12/202200:47GlobeNewswire Inc.Hillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies™ (HSB-1940) against PD-1, by combining Quatramers™ with OmniAb’s Picobodies™, via a Collaboration Agreement, against Novel, Unreachable and UndruggableNASDAQ:OABIOmniAb Inc
15/11/202223:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OABIOmniAb Inc
 Showing the most relevant articles for your search:NASDAQ:OABI